GLP-1 and GIP agonists were initially used for the treatment of diabetes and later as an indication for weight loss. These medications work by helping with insulin resistance that can contribute to weight gain and obesity. We utilize compounded versions of Semaglutide
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.